Please login to the form below

Not currently logged in
Email:
Password:

Valeant continues on acquisition trail

Canadian pharmaceutical company Valeant has reportedly made a takeover bid for Medicis Pharmaceutical

Valeant Pharmaceuticals has made a takeover bid for Medicis Pharmaceutical, according to The Wall Street Journal.

An acquisition of Medicis, which makes dermatological and aesthetic pharmaceutical products, would fit with Valeant's stated goal of becoming a leader in the sector. 

According to reports, Arizona-based Medicis has been left vulnerable to a takeover approach as its shares have underperformed the broader market following the unusual death of its chief executive Jonah Shacknai's girlfriend, who was found bound, nude and hanged from a balcony at his mansion near San Diego in July.

Valeant has been on the acquisition trail since it failed in May to acquire US rival Cephalon for $5.7bn. In February it bought the privately held firm PharmaSwiss for €350m in a move to strengthen its European presence. It acquired AC Santos in May, and in July 2011 it bought Sanofi's Dermik dermatology unit for $425m.

At the end of July Valeant was rumoured to be considering making a bid for Swedish-based pharmaceutical company Meda.

9th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics